Literature DB >> 1880718

Characterization of the degradation products of luteinizing hormone releasing hormone.

M G Motto1, P F Hamburg, D A Graden, C J Shaw, M L Cotter.   

Abstract

The degradation products of luteinizing hormone releasing hormone [LH/RH; 1; gonadorelin releasing hormone (GnRH); less than Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2] were determined in aqueous solution (pH 6.5) at 25, 37, 50, and 80 degrees C. The predominant route of degradation involved the cleavage of the less than Glu-His and Trp-Ser peptide bonds to give peptides 5-9 and hydrolysis of the terminal Gly-NH2 to the free acid form in peptides 4 and 10. Racemization of the serine and histidine residues to give peptides 2 and 3 was a second route of degradation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1880718     DOI: 10.1002/jps.2600800504

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Data analysis of kinetic modelling used in drug stability studies: isothermal versus nonisothermal assays.

Authors:  Alexis Oliva; Matías Llabrés; José B Fariña
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

2.  Degradation kinetics of three gonadorelin analogues: developing a method for calculating epimerization parameters.

Authors:  M A Hoitink; J H Beijnen; M U Boschma; A Bult; O A van der Houwen; G Wiese; W J Underberg
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

3.  Is stability prediction possible for protein drugs? Denaturation kinetics of beta-galactosidase in solution.

Authors:  S Yoshioka; Y Aso; K Izutsu; S Kojima
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.